Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid-lowering medications.

Jessica Rodenburg1, Maud N Vissers, Stephen R Daniels

  • 1Department of Vascular Medicine, Academic Medical Centre, University of Amsterdam, the Netherlands, and Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio, USA.

Pediatric Endocrinology Reviews : PER
|February 4, 2006
PubMed
Summary

Cholesterol-lowering treatments for children are expanding beyond diet. Statins and ezetimibe show promise for managing high LDL cholesterol in pediatric patients, offering new therapeutic options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

European heart journal·2026
Same author

Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry.

European heart journal·2026
Same author

Evinacumab with or without lipoprotein apheresis in homozygous familial hypercholesterolaemia.

European journal of preventive cardiology·2026
Same author

Cascade screening for elevated Lp(a) in relatives of children who visited the pediatric lipid clinic: yield of daily clinical practice.

European journal of preventive cardiology·2026
Same author

Statin-associated symptoms and statin intolerance in children with familial hypercholesterolemia: Insights from 15 years of clinical practice.

Atherosclerosis·2026
Same author

Baseline characteristics and response to evinacumab in females and males with homozygous familial hypercholesterolemia in the ELIPSE OLE study.

American journal of preventive cardiology·2026

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Pharmacology
  • Lipid Metabolism

Background:

  • Traditional cholesterol management in children under 10 focused on diet and lifestyle.
  • For older children, bile acid-binding resins were used but had limited efficacy and poor compliance.
  • Hypercholesterolemia treatment in adults primarily utilizes HMG-CoA reductase inhibitors (statins).

Purpose of the Study:

  • To review the evolving landscape of cholesterol-lowering agents for pediatric use.
  • To assess the efficacy and safety of emerging lipid-lowering drugs in children.
  • To provide an overview of current and novel therapeutic options for pediatric hypercholesterolemia.

Main Methods:

  • Review of recent randomized trials on statins in children.

Related Experiment Videos

  • Evaluation of ezetimibe's potential based on adult data and mechanism of action.
  • Consideration of other drug classes like fibrates and nicotinic acid for pediatric application.

    • Main Results:

    • Statins demonstrate effectiveness and short-term safety in reducing LDL cholesterol in children.
    • Ezetimibe, an intestinal cholesterol absorption inhibitor, shows potential but requires more pediatric data.
    • Fibrates and nicotinic acid are generally unsuitable for children due to side effect profiles.

    Conclusions:

    • Therapeutic options for lowering cholesterol in children are significantly expanding.
    • Statins represent a viable and effective treatment for pediatric hypercholesterolemia.
    • Further research is needed for ezetimibe, but it may offer a future alternative or adjunct therapy.